Exclude Patient Type Detail Header
No
Footnote
<sup>3</sup> Obtain blood cx [S/M] and consider microscopic exam/cx of cutaneous aspirate/bx/swab in pts w/ chemo-treated malignancy, neutropenia, severe CMI, immersion injury, or animal bites [W/M].<br><br><sup>4</sup> Tx of fissuring/scaling/maceration in interdigital spaces may eradicate pathogen colonization and reduce recurrent infxn [S/M].<br><br>
<sup>5</sup> Many clinicians include MSSA coverage [W/L].<br><br>
<sup>6</sup> If associated with penetrating trauma, MRSA infection elsewhere/nasal colonization, IVDA, purulent drainage [S/M]<br><br>
<sup>7</sup> If clinda resistance <10-15% at institution
<sup>5</sup> Many clinicians include MSSA coverage [W/L].<br><br>
<sup>6</sup> If associated with penetrating trauma, MRSA infection elsewhere/nasal colonization, IVDA, purulent drainage [S/M]<br><br>
<sup>7</sup> If clinda resistance <10-15% at institution
Detail Type
Text